Fatal Dengue in Patients with Sickle Cell Disease or Sickle Cell Anemia in Curaçao: Two Case Reports

PLoS Neglected Tropical Diseases

Volumn 7, Issue 8, 2013, Pages

  Moesker, Fleur M ^a   Muskiet, Fred D ^b   Koeijers, Jeanne J ^b   Fraaij, Pieter L A ^a,c   Gerstenbluth, Isaac ^d   van Gorp, Eric C M ^a   Osterhaus, Albert D M E ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Microvida Laboratory for Medical Microbiology and Immunology   (Netherlands)

^c SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^d Epidemiology and Research Unit   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; C REACTIVE PROTEIN; HEMOGLOBIN S; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INOTROPIC AGENT;

ABDOMINAL TENDERNESS; ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; ANURIA; ARTICLE; CAPILLARY LEAK SYNDROME; CASE REPORT; CHILD; CLONIC SEIZURE; COMPUTER ASSISTED TOMOGRAPHY; DENGUE; DENGUE VIRUS 2; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; EPISTAXIS; FEMALE; FEVER; HEADACHE; HEMATEMESIS; HEMATOCRIT; HEPATOSPLENOMEGALY; HUMAN; HYPERTRANSAMINASEMIA; HYPOTENSION; MALAISE; MULTIPLE ORGAN FAILURE; MYALGIA; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHOOL CHILD; SICKLE CELL ANEMIA; THROMBOCYTOPENIA;

EID: 84883444071     PISSN: 19352727     EISSN: 19352735     Source Type: Journal    
DOI: 10.1371/journal.pntd.0002203     Document Type: Article

References (13)

1. Dijs FP (2004) Sickle cell disease and α-thalassemia in Curaçao: contributors to epidemiology, pathophysiology and supportive care [dissertation]. Willemstad.
2. World Health Organization (2009) Dengue guidelines: diagnosis, treatment, prevention and control. New edition 2009. Geneva: World Health Organization. pp. 1-160.
3. World Health Organization (January 2011) Sickle-cell disease and other haemoglobin disorders. Fact sheet N°308. Available: http://www.who.int/mediacentre/factsheets/fs308/en/index.html. Accessed 5 July 2013.
4. Limonta D, González D, Capó V, Torres G, Pérez AB, et al. (2009) Fatal severe dengue and cell death in sickle cell disease during the 2001-2002 Havana dengue epidemic. Int J Infect Dis 13: 77-78.
5. Andrianarisoa ACE, Rakotoson J, Randretsa M, Rakotondravelo S, Rakotoarimanana RD, et al. (2007) Madagascar: public health situation on the "Big Island" at the beginning of the 21st century. Med Trop (Mars) 67: 19-29.
6. Ware MA, Hambleton I, Ochaya I, Serjeant GR, (1999) Day-care management of sickle cell painful crisis in Jamaica: a model applicable elsewhere? Br J Haematol 104: 93-96.
7. Teruel-López E, (1991) Dengue. A review. Invest Clin 32: 201-217.
8. Bravo JR, Guzmán MG, Kouri GP, (1987) Why dengue haemorrhagic fever in Cuba? 1. Individual risk factors for dengue haemorrhagic fever/dengue shock syndrome (DHF/DSS). Trans R Soc Trop Med Hyg 81: 816-820.
9. Gentilini M, Laroche V, Degremont A, (1964) Aspects of parasitic and infectious tropical pathology in the Republic of Haiti. Bull Soc Pathol Exot Filiales 57: 565-570.
10. González D, Castro OE, Kourí G, Perez J, Martinez E, et al. (2005) Classical dengue hemorrhagic fever resulting from two dengue infections spaced 20 years or more apart: Havana, Dengue 3 epidemic, 2001-2002. Int J Infect Dis 9: 280-285.
11. Martina BEE, Koraka P, Osterhaus ADME, (2009) Dengue virus pathogenesis: an integrated view. Clin Microbiol Rev 22: 564-581.
12. Rees DC, Williams TN, Gladwin MT, (2010) Sickle-cell disease. Lancet 376: 2018-2031.
13. Halstead SB, (2007) Dengue. Lancet 370: 1644-1652.